The prognostic impact of lymphoma perforation in patients with primary gastrointestinal lymphoma – a single-center analysis

References

• Ducreux M, Boutron MC, Piard F, et al. A 15-year series of gastrointestinal non-Hodgkin lymphomas: a population-based study. Br J Cancer. 1998;77(3):511–514. doi:10.1038/bjc.1998.82
   PubMed Web of Science ®Google Scholar
• Wu XC, Andrews P, Chen VW, et al. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences. Cancer Epidemiol. 2009;33(5):337–346. doi:10.1016/j.canep.2009.09.006
   PubMed Web of Science ®Google Scholar
• Gou HF, Zang J, Jiang M, et al. Clinical prognostic analysis of 116 patients with primary intestinal non-Hodgkin lymphoma. Med Oncol. 2012;29(1):227–234. doi:10.1007/s12032-010-9783-x
   PubMed Web of Science ®Google Scholar
• Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19(12):1992–1999. doi:10.1093/annonc/mdn525
   PubMed Web of Science ®Google Scholar
• Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972;29(1):252–260. doi:10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO;2-#
   PubMed Web of Science ®Google Scholar
• Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German multicenter study GIT NHL 01/92. J Clin Oncol. 2001;19(18):3861–3873. doi:10.1200/JCO.2001.19.18.3861
   PubMed Web of Science ®Google Scholar
• Dawson IM, Cornes JS, Morson BC. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961; 49:80–89. doi:10.1002/bjs.18004921319
   PubMed Web of Science ®Google Scholar
• Lewin KJ, Ranchod M, Dorfman RF. Lymphomas of the gastrointestinal tract: a study of 117 cases presenting with gastrointestinal disease. Cancer. 1978;42(2):693–707. doi:10.1002/1097-0142(197808)42:2<693::AID-CNCR2820420241>3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Vaidya R, Habermann TM, Donohue JH, et al. Bowel perforation in intestinal lymphoma: incidence and clinical features. Ann Oncol. 2013;24(9):2439–2443. doi:10.1093/annonc/mdt188
   PubMed Web of Science ®Google Scholar
• Papaxoinis G, Papageorgiou S, Rontogianni D, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a clinicopathologic study of 128 cases in Greece. A hellenic cooperative oncology group study (HeCOG). Leuk Lymphoma. 2006;47(10):2140–2146. doi:10.1080/10428190600709226
   PubMed Web of Science ®Google Scholar
• Koch P, del Valle F, Berdel WE, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: II. Combined surgical and conservative or conservative management only in localized gastric lymphoma–results of the prospective German multicenter study GIT NHL 01/92. J Clin Oncol. 2001;19(18):3874–3883. doi:10.1200/JCO.2001.19.18.3874
   PubMed Web of Science ®Google Scholar
• Zinzani PL, Magagnoli M, Pagliani G, et al. Primary intestinal lymphoma: clinical and therapeutic features of 32 patients. Haematologica. 1997;82(3):305–308.
   PubMed Web of Science ®Google Scholar
• Binn M, Ruskone-Fourmestraux A, Lepage E, et al. Surgical resection plus chemotherapy versus chemotherapy alone: comparison of two strategies to treat diffuse large B-cell gastric lymphoma. Ann Oncol. 2003;14(12):1751–1757. doi:10.1093/annonc/mdg495
   PubMed Web of Science ®Google Scholar
• Amer MH, el-Akkad S. Gastrointestinal lymphoma in adults: clinical features and management of 300 cases. Gastroenterology. 1994;106(4):846–858. doi:10.1016/0016-5085(94)90742-0
   PubMed Web of Science ®Google Scholar
• d‘Amore F, Brincker H, Gronbaek K, et al. Non-Hodgkin lymphoma of the gastrointestinal tract: a population-based analysis of incidence, geographic distribution, clinicopathologic presentation features, and prognosis. Danish lymphoma study group. J Clin Oncol. 1994;12(8):1673–1684. doi:10.1200/JCO.1994.12.8.1673
   PubMed Web of Science ®Google Scholar
• Daum S, Ullrich R, Heise W, et al. Intestinal non-Hodgkin’s lymphoma: a multicenter prospective clinical study from the German study group on intestinal non-Hodgkin’s lymphoma. J Clin Oncol. 2003;21(14):2740–2746. doi:10.1200/JCO.2003.06.026
   PubMed Web of Science ®Google Scholar
• Dincol D, Icli F, Erekul S, et al. Primary gastrointestinal lymphomas in Turkey: a retrospective analysis of clinical features and results of treatment. J Surg Oncol. 1992;51(4):270–273. doi:10.1002/jso.2930510414
   PubMed Web of Science ®Google Scholar
• Economopoulos T, Alexopoulos C, Stathakis N, et al. Primary gastric lymphoma–the experience of a general hospital. Br J Cancer. 1985;52(3):391–397. doi:10.1038/bjc.1985.206
   PubMed Web of Science ®Google Scholar
• Gobbi PG, Dionigi P, Barbieri F, et al. The role of surgery in the multimodal treatment of primary gastric non-Hodgkin’s lymphomas. A report of 76 cases and review of the literature. Cancer. 1990;65(11):2528–2536. doi:10.1002/1097-0142(19900601)65:11<2528::AID-CNCR2820651123>3.0.CO;2-W
   PubMed Web of Science ®Google Scholar
• Ibrahim EM, Ezzat AA, El-Weshi AN, et al. Primary intestinal diffuse large B-cell non-Hodgkin’s lymphoma: clinical features, management, and prognosis of 66 patients. Ann Oncol. 2001;12(1):53–58. doi:10.1023/a:1008389001990
   PubMed Web of Science ®Google Scholar
• Kako S, Oshima K, Sato M, et al. Clinical outcome in patients with small-intestinal non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50(10):1618–1624. doi:10.1080/10428190903147629
   PubMed Web of Science ®Google Scholar
• Kim SJ, Choi CW, Mun YC, et al. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the consortium for improving survival of lymphoma (CISL). BMC Cancer. 2011;11:321. doi:10.1186/1471-2407-11-321
   PubMed Web of Science ®Google Scholar
• Kim SJ, Kang HJ, Kim JS, et al. Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy alone. Blood. 2011;117(6):1958–1965. doi:10.1182/blood-2010-06-288480
   PubMed Web of Science ®Google Scholar
• Lee J, Kim WS, Kim K, et al. Intestinal lymphoma: exploration of the prognostic factors and the optimal treatment. Leuk Lymphoma. 2004;45(2):339–344. doi:10.1080/10428190310001593111
   PubMed Web of Science ®Google Scholar
• Li M, Zhang S, Gu F, et al. Clinicopathological characteristics and prognostic factors of primary gastrointestinal lymphoma: a 22-year experience from South China. Int J Clin Exp Pathol. 2014;7(5):2718–2728.
   PubMed Web of Science ®Google Scholar
• Lin KM, Penney DG, Mahmoud A, et al. Advantage of surgery and adjuvant chemotherapy in the treatment of primary gastrointestinal lymphoma. J Surg Oncol. 1997;64(3):237–241. doi:10.1002/(SICI)1096-9098(199703)64:3<237::AID-JSO11>3.0.CO;2-1
   PubMed Web of Science ®Google Scholar
• Maisey N, Norman A, Prior Y, et al. Chemotherapy for primary gastric lymphoma: does in-patient observation prevent complications? Clin Oncol (R Coll Radiol). 2004;16(1):48–52. doi:10.1016/s0936-6555(03)00250-4
   PubMed Web of Science ®Google Scholar
• Morton JE, Leyland MJ, Vaughan Hudson G, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: a review of 175 British National lymphoma investigation cases. Br J Cancer. 1993;67(4):776–782. doi:10.1038/bjc.1993.141
   PubMed Web of Science ®Google Scholar
• Nakamura S, Matsumoto T, Iida M, et al. Primary gastrointestinal lymphoma in Japan: a clinicopathologic analysis of 455 patients with special reference to its time trends. Cancer. 2003;97(10):2462–2473. doi:10.1002/cncr.11415
   PubMed Web of Science ®Google Scholar
• Rabbi C, Aitini E, Cavazzini G, et al. Stomach preservation in low- and high-grade primary gastric lymphomas: preliminary results. Haematologica. 1996;81(1):15–19.
   PubMed Web of Science ®Google Scholar
• Raderer M, Valencak J, OSterreicher C, et al. Chemotherapy for the treatment of patients with primary high grade gastric B-cell lymphoma of modified ann arbor stages IE and IIE. Cancer. 2000;88(9):1979–1985. doi:10.1002/(SICI)1097-0142(20000501)88:9<1979::AID-CNCR1>3.0.CO;2-L
   PubMed Web of Science ®Google Scholar
• Radman I, Kovacevic-Metelko J, Aurer I, et al. Surgical resection in the treatment of primary gastrointestinal non-Hodgkin’s lymphoma: retrospective study. Croat Med J. 2002;43(5):555–560.
   PubMed Web of Science ®Google Scholar
• Salles G, Herbrecht R, Tilly H, et al. Aggressive primary gastrointestinal lymphomas: review of 91 patients treated with the LNH-84 regimen. A study of the Groupe d‘Etude des lymphomes agressifs. Am J Med. 1991;90(1):77–84. Jandoi:10.1016/0002-9343(91)90509-v
   PubMed Web of Science ®Google Scholar
• Shepherd NA, Hall PA, Coates PJ, et al. Primary malignant lymphoma of the colon and rectum. A histopathological and immunohistochemical analysis of 45 cases with clinicopathological correlations. Histopathology. 1988;12(3):235–252. doi:10.1111/j.1365-2559.1988.tb01939.x
   PubMed Web of Science ®Google Scholar
• Talamonti MS, Dawes LG, Joehl RJ, et al. Gastrointestinal lymphoma. A case for primary surgical resection. Arch Surg. 1990;125(8):972–976. doi:10.1001/archsurg.1990.01410200030003
   PubMedGoogle Scholar
• Tondini C, Giardini R, Bozzetti F, et al. Combined modality treatment for primary gastrointestinal non-Hodgkin’s lymphoma: the Milan cancer institute experience. Ann Oncol. 1993;4(10):831–837. Decdoi:10.1093/oxfordjournals.annonc.a058388
   PubMed Web of Science ®Google Scholar
• Tondini C, Balzarotti M, Santoro A, et al. Initial chemotherapy for primary resectable large-cell lymphoma of the stomach. Ann Oncol. 1997;8(5):497–499. doi:10.1023/a:1008206329583
   PubMed Web of Science ®Google Scholar
• Chuang SS, Ye H, Yang SF, et al. Perforation predicts poor prognosis in patients with primary intestinal diffuse large B-cell lymphoma. Histopathology. 2008;53(4):432–440. doi:10.1111/j.1365-2559.2008.03140.x
   PubMed Web of Science ®Google Scholar
• Huang J, Jiang W, Xu R, et al. Primary gastric non-Hodgkin’s lymphoma in Chinese patients: clinical characteristics and prognostic factors. BMC Cancer. 2010;10:358. doi:10.1186/1471-2407-10-358
   PubMed Web of Science ®Google Scholar
• Khosla D, Kumar R, Kapoor R, et al. A retrospective analysis of clinicopathological characteristics, treatment, and outcome of 27 patients of primary intestinal lymphomas. J Gastrointest Cancer. 2013;44(4):417–421. doi:10.1007/s12029-013-9519-1
   PubMedGoogle Scholar
• Shi Z, Ding H, Shen QW, et al. The clinical manifestation, survival outcome and predictive prognostic factors of 137 patients with primary gastrointestinal lymphoma (PGIL): strobe compliant. Medicine. 2018;97(1):e9583. doi:10.1097/MD.0000000000009583
   PubMed Web of Science ®Google Scholar
• Zhang S, Wang L, Yu D, et al. Localized primary gastrointestinal diffuse large B cell lymphoma received a surgical approach: an analysis of prognostic factors and comparison of staging systems in 101 patients from a single institution. World J Surg Oncol. 2015;13:246. doi:10.1186/s12957-015-0668-5
   PubMed Web of Science ®Google Scholar
• Lister TA, Crowther D, Sutcliffe SB, et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin’s disease: cotswolds meeting. J Clin Oncol. 1989;7(11):1630–1636. doi:10.1200/JCO.1989.7.11.1630
   PubMed Web of Science ®Google Scholar
• Varghese C, Jose CC, Subhashini J, et al. Primary small intestinal lymphoma. Oncology. 1992;49(5):340–342. doi:10.1159/000227069
   PubMed Web of Science ®Google Scholar
• Azab MB, Henry-Amar M, Rougier P, et al. Prognostic factors in primary gastrointestinal non-Hodgkin’s lymphoma. A multivariate analysis, report of 106 cases, and review of the literature. Cancer. 1989;64(6):1208–1217. doi:10.1002/1097-0142(19890915)64:6<1208::AID-CNCR2820640608>3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Aviles A, Garcia EL, Fernandez R, et al. Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy. Ann Hematol. 2002;81(7):368–373.
   PubMed Web of Science ®Google Scholar
• Katipamula R, Ristow K, Colgan JP, et al. Primary diffuse large B-cell lymphoma of the colon: surgery for local disease control does not improve outcome. Blood. 2007;110(11):3444–3444. doi:10.1182/blood.V110.11.3444.3444
   Web of Science ®Google Scholar
• Ruskone-Fourmestraux A, Aegerter P, Delmer A, et al. Primary digestive tract lymphoma: a prospective multicentric study of 91 patients. Groupe d‘Etude des lymphomes digestifs. Gastroenterology. 1993;105(6):1662–1671. doi:10.1016/0016-5085(93)91061-l
   PubMed Web of Science ®Google Scholar
• Ampil FL. Primary gastrointestinal lymphoma. Oncology. 1987;44(4):214–218. doi:10.1159/000226480
   PubMed Web of Science ®Google Scholar
• Aozasa K, Tsujimoto M, Inoue A, et al. Primary gastrointestinal lymphoma. A clinicopathologic study of 102 patients. Oncology. 1985;42(2):97–103. doi:10.1159/000226009
   PubMed Web of Science ®Google Scholar
• Chihara D, Oki Y, Ine S, et al. Primary gastric diffuse large B-cell lymphoma (DLBCL): analyses of prognostic factors and value of pretreatment FDG-PET scan. Eur J Haematol. 2010;84(6):493–498. doi:10.1111/j.1600-0609.2010.01426.x
   PubMed Web of Science ®Google Scholar
• Fischbach W, Dragosics B, Kolve-Goebeler ME, et al. Primary gastric B-cell lymphoma: results of a prospective multicenter study. The German-Austrian gastrointestinal lymphoma study group. Gastroenterology. 2000;119(5):1191–1202. doi:10.1053/gast.2000.19579
   PubMed Web of Science ®Google Scholar
• Koch P, Grothaus-Pinke B, Hiddemann W, et al. Primary lymphoma of the stomach: three-year results of a prospective multicenter study. The German multicenter study group on GI-NHL. Ann Oncol. 1997;8(Suppl 1):85–88.
   PubMedGoogle Scholar
• Lee J, Kim WS, Kim K, et al. Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma. Leuk Res. 2007;31(3):359–364. doi:10.1016/j.leukres.2006.06.018
   PubMed Web of Science ®Google Scholar
• Li B, Shi YK, He XH, et al. Primary non-Hodgkin lymphomas in the small and large intestine: clinicopathological characteristics and management of 40 patients. Int J Hematol. 2008;87(4):375–381. doi:10.1007/s12185-008-0068-5
   PubMed Web of Science ®Google Scholar
• Medina-Franco H, Germes SS, Maldonado CL. Prognostic factors in primary gastric lymphoma. Ann Surg Oncol. 2007;14(8):2239–2245. doi:10.1245/s10434-006-9244-0
   PubMed Web of Science ®Google Scholar
• Mihaljevic B, Nedeljkov-Jancic R, Vujicic V, et al. Primary extranodal lymphomas of gastrointestinal localizations: a single institution 5-yr experience. MO. 2006;23(2):225–236. doi:10.1385/MO:23:2:225
   Google Scholar
• Musallam KM, Hatoum HA, Barada K, et al. Primary colorectal lymphoma. Med Oncol. 2010;27(2):249–254. doi:10.1007/s12032-009-9200-5
   PubMed Web of Science ®Google Scholar
• Willich NA, Reinartz G, Horst EJ, et al. Operative and conservative management of primary gastric lymphoma: interim results of a German multicenter study. Int J Radiat Oncol Biol Phys. 2000;46(4):895–901. doi:10.1016/s0360-3016(99)00475-7
   PubMed Web of Science ®Google Scholar
• Dizengof V, Levi I, Etzion O, et al. Incidence rates and clinical characteristics of primary gastrointestinal non-Hodgkin lymphoma: a population study. Eur J Gastroenterol Hepatol. 2020;32(5):569–574. doi:10.1097/MEG.0000000000001651
   PubMed Web of Science ®Google Scholar
• Wang YG, Zhao LY, Liu CQ, et al. Clinical characteristics and prognostic factors of primary gastric lymphoma: a retrospective study with 165 cases. Medicine. 2016;95(31):e4250. doi:10.1097/MD.0000000000004250
   PubMed Web of Science ®Google Scholar
• Zhang C, Zhang X, Liu Z, et al. The impact of surgery on long-term survival of patients with primary intestinal non-Hodgkin lymphomas based on SEER database. Sci Rep. 2021;11(1):23047. doi:10.1038/s41598-021-02597-1
   PubMed Web of Science ®Google Scholar
• Zhao F, Qin Y, Yang J, et al. R-CHOP immunochemotherapy plus surgery is associated with a superior prognosis in Chinese primary intestinal diffuse large B-cell lymphoma. Asia Pac J Clin Oncol. 2020;16(6):385–391. doi:10.1111/ajco.13396
   PubMed Web of Science ®Google Scholar